Pamela Vig, CHIEF SCIENTIFIC OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 30,559 shares at $34.00 ($1.0M) on 2024-06-24, disclosed to the SEC on 2024-06-25.
Scheduled sale ($1.0M) by CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2024-01-09 | $39K | — | Filing → |
| MIRM | SELL | 2023-07-05 | $37K | — | Filing → |
| MIRM | SELL | 2021-10-01 | $26K | — | Filing → |